Mamoor, S. (2025). Therapeutic targeting in androgen receptor-positive triple negative breast cancer (AR+ TNBC): THTPA. Zenodo.
Cita Chicago Style (17a ed.)Mamoor, Shahan. Therapeutic Targeting in Androgen Receptor-positive Triple Negative Breast Cancer (AR+ TNBC): THTPA. Zenodo, 2025.
Cita MLA (9a ed.)Mamoor, Shahan. Therapeutic Targeting in Androgen Receptor-positive Triple Negative Breast Cancer (AR+ TNBC): THTPA. Zenodo, 2025.
Precaución: Estas citas no son 100% exactas.